Found: 2
Select item for more details and to access through your institution.
Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 4, p. 635, doi. 10.1038/sj.leu.2404136
- By:
- Publication type:
- Article
Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning.
- Published in:
- British Journal of Pharmacology, 1999, v. 126, n. 3, p. 701, doi. 10.1038/sj.bjp.0702368
- By:
- Publication type:
- Article